Suggestions
Sameer Kothari
A seasoned CEO within the life sciences, taking early-stage technology and establishing a commercial strategy, including fundraising and executing this to successful launch of products.
Sameer Kothari is the recently appointed Chief Commercial Officer (CCO) at Health Innovation Manchester, joining the organization in January 2024.12 He brings extensive experience in the healthcare and technology sectors to this role.
Professional Background
Prior to joining Health Innovation Manchester, Sameer served as the CEO of Zilico Limited, a company specializing in cancer diagnostics.13 At Zilico, he successfully led the development and launch of their flagship product in the cancer diagnostics field.2 His tenure at Zilico lasted from 2007 to 2024, demonstrating his long-term commitment and leadership in the medical technology industry.4
Previous Roles and Achievements
Sameer's career history includes several notable positions:
- CEO of Plasso Technology Ltd (2003-2007), a venture capital-backed company developing research tools for life sciences24
- Senior executive at Marconi plc (1996-2002), where he held roles in strategy, business development, HR, and mergers and acquisitions, including a board position in Europe24
Responsibilities at Health Innovation Manchester
As Chief Commercial Officer, Sameer is tasked with:
- Executing Health Innovation Manchester's commercial plan
- Developing partnerships with SMEs and global industry players
- Delivering on the organization's commercial objectives13
Additional Roles and Achievements
Sameer's professional involvement extends beyond his primary career:
- Founding council member of the Bessemer Society, a forum for CEOs and entrepreneurs in technological innovation4
- Fellow of the Winston Churchill Memorial Trust and the British American Project4
- Executive in Residence at Sheffield Business School4
- Board Governor at Hunter's Bar Junior School4
Sameer Kothari's appointment at Health Innovation Manchester is part of a strategic move to strengthen the organization's leadership team and enhance its commercial capabilities in the healthcare innovation sector.1